NCT05982626View on ClinicalTrials.gov

Study of 68Ga /131I SGMIB-ZT-199 PET Imaging Targeting HER2-positive in the Diagnosis of Metastatic Breast Cancer

NARecruitingINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

May 15, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

March 31, 2025

Conditions

HER2-positive Breast Cancer

Interventions

RADIATION

68Ga/131I-SGMIB-ZT-199

68Ga-SGMIB-ZT-199: PET imaging; 131I-SGMIB-ZT-199: SPECT imaging.

Trial Locations (1)

200040

RECRUITING

Huashan Hospital, Shanghai

All Listed Sponsors

lead

Huashan Hospital

OTHER